SML0814

ESI-09

≥98% (HPLC)

• Synonym(e): α-[2-(3-Chlorophenyl)hydrazinylidene]-5-(1,1-dimethylethyl)-b-oxo-3-isoxazolepropanenitrile
• Empirische Formel (Hill-System): C₁₆H₁₅ClN₄O₂
• CAS-Nummer: 263707-16-0
• Molekulargewicht: 330.77
• UNSPSC-Code: 41106305
• NACRES: NA.77

Eigenschaften

• Qualitätsniveau: 100
• Assay: ≥98% (HPLC)
• Form: powder
• Farbe: , faint yellow to dark orange
• Löslichkeit: DMSO: 20 mg/mL, clear
• Lagertemp.: 2-8°C
• InChI: 1S/C16H15ClN4O2/c1-16(2,3)14-8-12(21-23-14)15(22)13(9-18)20-19-11-6-4-5-10(17)7-11/h4-8,19H,1-3H3/b20-13+
• InChIKey: DXEATJQGQHDURZ-DEDYPNTBSA-N

Beschreibung

Anwendung

ESI-09 has been used as an antagonist for exchange factor directly activated by cAMP (EPAC).

Biochem./physiol. Wirkung

ESI-09 is a potent, specific inhibitor of EPAC (exchange protein directly activated by cAMP). ESI-09 inhibits EPAC1 and EPAC2 with IC₅₀ values of 3.2 and 1.4 μM, respectively, with no activity against PKA at 25 μM. In pancreatic cell lines, the compound blocks phosphorylation of Akt and insulin secretion. ESI-09 inhibits migration of pancreatic cancer cell lines.

Sicherheitshinweise

• Lagerklassenschlüssel: 11 - Combustible Solids
• WGK: WGK 3
• Flammpunkt (°F): Not applicable
• Flammpunkt (°C): Not applicable